PuSH - Publication Server of Helmholtz Zentrum München

29 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Jaghutriz, B.A. et al.: Gene x gene interactions highlight the role of incretin resistance for insulin secretion. Front. Endocrin. 10:72 (2019)
2.
Keuper, M. et al.: Preadipocytes of obese humans display gender-specific bioenergetic responses to glucose and insulin. Mol. Metab. 20, 28-37 (2019)
3.
Lutz, S.Z. et al.: Sex-specific associations of testosterone with metabolic traits. Front. Endocrin. 10:90 (2019)
4.
Fritsche, L. et al.: Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits. Diabetes Res. Clin. Pract. 146, 251-257 (2018)
5.
Gerlini, R. et al.: Glucose tolerance and insulin sensitivity define adipocyte transcriptional programs in human obesity. Mol. Metab. 18, 42-50 (2018)
6.
Kantartzis, K. et al.: Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Obes. Metab. 20, 1793-1797 (2018)
7.
Liu, X.* et al.: Quality control of serum and plasma by quantification of (4E, 14Z)-sphingadienine-C18-1-phosphate uncovers common preanalytical errors during handling of whole blood. Clin. Chem. 64, 810-819 (2018)
8.
Stirm, L. et al.: Maternal whole blood cell miRNA-340 is elevated in gestational diabetes and inversely regulated by glucose and insulin. Sci. Rep. 8:1366 (2018)
9.
Stirm, L. et al.: BMI-independent effects of gestational diabetes on human placenta. J. Clin. Endocrinol. Metab. 103, 3299-3309 (2018)
10.
Baumeier, C.* et al.: Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Mol. Metab. 6, 1254-1263 (2017)
11.
Fehlert, E. et al.: Genetic determination of body fat distribution and the attributive influence on metabolism. Obesity 25, 1277-1283 (2017)
12.
Fehlert, E. et al.: Gestational diabetes alters the fetal heart rate variability during an oral glucose tolerance test: a fetal magnetocardiography study. BJOG 124, 1891-1898 (2017)
13.
Linder, K. et al.: Gestational diabetes impairs human fetal postprandial brain activity (vol 100, pg 4029, 2015). J. Clin. Endocrinol. Metab. 102, 336-336 (2017)
14.
Lutz, S.Z. et al.: Androgen receptor overexpression in prostate cancer in type 2 diabetes. Mol. Metab. 8, 158-166:doi:10.1016/j.molmet.2017.11.013 (2017)
15.
Schmid, V.* et al.: Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: Results from the TULIP study. Diabetologia 60, 2341-2351 (2017)
16.
Stirm, L. ; Fritsche, L. ; Fritsche, A. ; Häring, H.-U. & Staiger, H.: Apelinergic system in placenta of women with gestational diabetes. Diabetologia 60, S44-S44 (2017)
17.
Wagner, R. et al.: Erratum to: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 54, 713-714 (2017)
18.
Wagner, R. et al.: Excessive fuel availability amplifies the FTO-mediated obesity risk: Results from the TUEF and Whitehall II studies. Sci. Rep. 7:15486 (2017)
19.
Sailer, C. et al.: FTO genotype interacts with improvement in aerobic fitness on body weight loss during lifestyle intervention. Obes. Facts 9, 174-181 (2016)
20.
Schmid, V. et al.: Liver fat content and insulin secretion failure are associated with the long-term success of a lifestyle intervention to prevent type 2 diabetes: Results of the TULIP study. Diabetologia 59, S171-S171 (2016)